Chem Sci 12(27):94859493 Barnham KJ, Kenche VB, Ciccotosto GD, Smith DP, Tew DJ, Liu X, Perez K, Cranston GA, Johanssen TJ, Volitakis I, Bush AI (2008) Platinum-based inhibitors of amyloid- as therapeutic agents for Alzheimers disease
GLP-1s may improve insulin sensitivity and support weight loss, both of which can help regulate cycles and improve symptoms in women with PCOS
GLP-1 receptor agonist therapies have become one of the fastest-growing segments in the global pharmaceutical market
It makes sense, then, that she would choose to join Holland & Barrett in the midst of a major transformation effort its 2025 financial year marked the largest investment period in the companys history as it spent on its store estate and digital capabilities, with the aim of ensuring that, as Bajaj puts it, the 100 year old business will be here in another 150 years
Zuckerman says that the rise of telemedicine and direct-to-consumer marketing, and a greater focus on lifestyle medications, has led to an increased interest in unapproved drugs such as peptide injectables
